June 25, 2018
Enabling Innovation and Creating Value Our Approach to Pharmaceutical Pricing
By Mark J. Alles, Chairman and Chief Executive Officer, Celgene Corporation
-
-
-
June 4, 2018Hitting Moving Targets in Lung Cancer Subtypes
Complex lung cancer subtypes call for new treatment strategies. -
-
June 2, 2018CAR T Cell Research Continues to Advance
Updated results from ongoing trials are shedding light on their efficacy and safety. -
June 2, 2018We Can't Afford Not To Innovate and Provide Access to the Best Multiple Myeloma Care Possible
Innovation continues to are provide tremendous value to patients and society.
